Book Cover
Home  |   Healthcare   |  Oxygen Therapy Market

Oxygen Therapy Market Size, Share, Growth, and Industry Analysis, By Type (Oxygen Source Equipment,Oxygen Delivery DevicesS), By Application (Chronic Obstructive Pulmonary Disease,Asthma,Obstructive Sleep Apnea,Respiratory Distress Syndrome,Cystic Fibrosis,Pneumonia,Others), Regional Insights and Forecast to 2035

Trust Icon
1000+
GLOBAL LEADERS TRUST US

Oxygen Therapy Market Overview

The global Oxygen Therapy Market in terms of revenue was estimated to be worth USD 18104.97 Million in 2026 and is poised to reach USD 45197.48 Million by 2035, growing at a CAGR of 10.7% from 2026 to 2035.

The Oxygen Therapy Market is witnessing strong expansion due to the increasing prevalence of respiratory disorders, rising aging population, and growing demand for advanced respiratory care solutions. Oxygen therapy has become an essential treatment approach for patients suffering from chronic respiratory conditions, post-surgical complications, and acute breathing disorders. In 2026, more than 500 million people globally are estimated to experience chronic respiratory health challenges, increasing the need for reliable oxygen support systems. Advancements in portable oxygen technologies, home-based respiratory care, and improved oxygen delivery devices are encouraging wider adoption across hospitals, clinics, and home healthcare settings. Healthcare providers are increasingly focusing on patient-centered oxygen management solutions that improve mobility, comfort, and treatment efficiency.

The United States represents a significant market for oxygen therapy solutions due to the high burden of respiratory diseases, advanced healthcare infrastructure, and increasing adoption of home oxygen therapy systems. More than 16 million adults in the country are affected by chronic respiratory conditions, creating continuous demand for oxygen source equipment and oxygen delivery devices. The growing preference for home healthcare services, remote patient monitoring, and portable respiratory technologies is supporting market growth. Healthcare facilities are also investing in advanced oxygen systems to improve patient outcomes, particularly for Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnea, and Respiratory Distress Syndrome applications.

Global Oxygen Therapy Market Size, 2035 (USD Million)

Get Comprehensive Insights into the Market’s Size and Growth Trends

downloadDownload FREE Sample

Key Findings

  • Market Driver: Rising respiratory disease prevalence is accelerating oxygen therapy adoption, with over 300 million people globally requiring respiratory care support across multiple chronic and acute conditions.
  • Major Market Restraint: High equipment costs restrict adoption in developing regions, with nearly 35% of patients facing affordability challenges for advanced oxygen therapy solutions.
  • Emerging Trends: Portable oxygen technologies are transforming patient care, with approximately 45% of new respiratory devices emphasizing mobility and home-based treatment capabilities.
  • Regional Leadership: North America leads the market due to healthcare advancement, accounting for nearly 38% share supported by strong demand for respiratory care devices.
  • Competitive Landscape: Companies are expanding product portfolios, with more than 20 major oxygen therapy innovations introduced recently to improve device efficiency and patient convenience.
  • Market Segmentation: Oxygen Delivery Devices dominate with nearly 55% share, while Chronic Obstructive Pulmonary Disease applications represent around 40% of demand due to increasing respiratory disease cases.
  • Recent Development: Advanced home oxygen solutions are gaining adoption, with over 50% of respiratory care providers focusing on remote monitoring and portable treatment technologies.

The Oxygen Therapy Market is experiencing increased demand for portable and lightweight oxygen solutions as healthcare systems shift toward home-based treatment models. Patients with chronic respiratory disorders are increasingly preferring oxygen delivery devices that provide greater mobility and independence compared with traditional stationary systems. In 2026, more than half of newly adopted oxygen therapy devices are expected to focus on compact designs, energy efficiency, and improved usability. Manufacturers are developing advanced portable concentrators and smart oxygen management systems to support long-term respiratory care outside hospital environments.

Another important trend is the integration of digital technologies into oxygen therapy equipment. Connected oxygen devices with monitoring capabilities are improving treatment tracking, healthcare provider communication, and patient compliance. Approximately 45% of newly developed respiratory care platforms are incorporating digital monitoring features to enhance clinical decision-making. Hospitals and home healthcare providers are increasingly adopting technology-enabled oxygen solutions for managing patients with Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnea, and other respiratory conditions.

Oxygen Therapy Market Dynamics

Driver

"Increasing respiratory disease burden drives oxygen therapy demand."

The rising prevalence of respiratory disorders is a major factor supporting the growth of the Oxygen Therapy Market. Chronic respiratory diseases, including Chronic Obstructive Pulmonary Disease and Asthma, continue increasing worldwide due to aging populations, environmental pollution, and lifestyle-related health risks. More than 300 million people globally are affected by asthma, while millions require long-term oxygen support for chronic breathing conditions. Oxygen therapy provides essential respiratory assistance by improving oxygen levels and enhancing patient quality of life. Increasing hospital admissions related to respiratory complications and growing home healthcare adoption are further strengthening demand for oxygen source equipment and oxygen delivery devices.

Restraint

"High equipment costs limit accessibility in emerging markets."

The cost associated with advanced oxygen therapy equipment remains a key challenge affecting adoption, particularly in low-income healthcare markets. Portable oxygen concentrators, specialized oxygen delivery devices, and maintenance requirements can create financial barriers for patients and healthcare providers. Approximately 35% of patients in developing regions experience difficulties accessing advanced respiratory care technologies due to affordability limitations. Limited healthcare reimbursement coverage and uneven availability of respiratory care infrastructure further restrict market penetration. Manufacturers are focusing on cost-effective solutions and simplified device designs to improve accessibility across underserved regions.

Opportunity

"Expansion of home healthcare creates new growth opportunities."

The increasing shift toward home-based healthcare presents significant opportunities for oxygen therapy solution providers. Patients with chronic respiratory conditions are increasingly receiving long-term oxygen treatment outside hospitals due to improved device portability and remote monitoring capabilities. More than 50% of respiratory care providers are expanding home oxygen therapy programs to reduce hospitalization pressure and improve patient convenience. Growth in elderly populations, increasing healthcare awareness, and technological advancements in oxygen delivery devices are creating new opportunities for manufacturers. Emerging economies are also investing in healthcare infrastructure, supporting broader adoption of oxygen therapy solutions.

Challenge

"Technical limitations and maintenance requirements affect adoption."

Maintaining oxygen therapy equipment performance and ensuring reliable oxygen supply remain important challenges for healthcare providers and patients. Oxygen source equipment requires regular maintenance, quality monitoring, and proper handling to ensure safe operation. Nearly 40% of healthcare facilities in developing markets face challenges related to equipment servicing and technical support availability. Device reliability, battery performance limitations in portable systems, and training requirements can influence adoption decisions. Companies are addressing these challenges through improved product designs, enhanced service networks, and user-friendly oxygen management technologies.

Oxygen Therapy Market Segmentation

Global Oxygen Therapy Market Size, 2035

Get Comprehensive Insights on the Market Segmentation in this Report

download Download FREE Sample

By Type

Oxygen Source Equipment: Oxygen Source Equipment represents a major segment of the Oxygen Therapy Market as hospitals, clinics, and home healthcare providers increasingly require reliable oxygen generation and supply systems. This segment includes equipment designed to produce and provide medical-grade oxygen for patients requiring continuous respiratory support. Oxygen Source Equipment is estimated to account for approximately 45% of the overall market share in 2026, supported by rising demand from healthcare facilities managing chronic respiratory conditions.

The increasing adoption of oxygen concentrators, oxygen generation systems, and advanced respiratory support infrastructure is strengthening this segment. More than 55% of healthcare providers are focusing on improving oxygen availability through efficient source equipment, particularly in regions experiencing increasing respiratory disease cases and expanding healthcare infrastructure.

Oxygen Delivery Devices: Oxygen Delivery Devices represent the leading product type in the Oxygen Therapy Market, accounting for approximately 55% of market share in 2026. These devices include systems that deliver oxygen directly to patients through different treatment approaches, supporting both clinical and home-based respiratory care. Growing preference for portable and patient-friendly oxygen delivery solutions is increasing demand across multiple healthcare settings.

The segment is benefiting from rising adoption among patients requiring long-term oxygen therapy for conditions such as Chronic Obstructive Pulmonary Disease and Respiratory Distress Syndrome. Nearly 60% of newly developed oxygen therapy products are focused on improving delivery efficiency, mobility, and patient comfort, supporting continued segment expansion.

By Application

Chronic Obstructive Pulmonary Disease: Chronic Obstructive Pulmonary Disease is the largest application segment in the Oxygen Therapy Market due to the increasing global burden of chronic respiratory disorders. This segment is estimated to hold approximately 40% market share in 2026 as oxygen therapy remains a critical treatment option for patients experiencing reduced oxygen levels and breathing difficulties.

The growing elderly population and increasing exposure to air pollution are contributing to higher COPD prevalence worldwide. More than 200 million people are estimated to experience COPD-related health challenges, creating continuous demand for oxygen source equipment and oxygen delivery devices.

Asthma: Asthma represents a significant application area, accounting for approximately 15% of the Oxygen Therapy Market share in 2026. Oxygen therapy is increasingly used in emergency and severe asthma cases where patients experience respiratory distress and reduced oxygen saturation levels.

Increasing awareness of respiratory disease management and improved emergency healthcare systems are supporting demand for oxygen therapy solutions. More than 300 million people globally are affected by asthma, encouraging healthcare providers to maintain advanced respiratory support capabilities.

Obstructive Sleep Apnea: Obstructive Sleep Apnea contributes nearly 12% of market demand due to increasing diagnosis rates and growing awareness regarding sleep-related breathing disorders. Oxygen therapy solutions are being explored alongside other respiratory support approaches to improve oxygen levels in affected patients.

The rising prevalence of obesity, aging populations, and sleep-related health concerns is increasing demand for respiratory care devices.Adults in developed regions experience some level of sleep apnea symptoms, supporting continued adoption of advanced oxygen therapy solutions.

Respiratory Distress Syndrome: Respiratory Distress Syndrome represents around 10% of the Oxygen Therapy Market share and remains an important application in neonatal and critical care environments. Oxygen therapy plays a vital role in supporting patients experiencing severe respiratory difficulties and oxygen deficiency.

Hospitals are increasingly investing in advanced oxygen delivery systems to improve intensive care capabilities. More than critical care facilities prioritize respiratory support technologies to enhance treatment outcomes for patients requiring immediate oxygen assistance.

Cystic Fibrosis: Cystic Fibrosis accounts for approximately 8% of oxygen therapy demand as patients with this condition often require long-term respiratory support. Oxygen therapy helps improve oxygen availability and supports quality of life for individuals experiencing chronic lung complications.

Increasing availability of specialized respiratory care programs and improved disease management approaches are supporting adoption. Around 70,000 people globally are affected by cystic fibrosis, creating consistent demand for advanced oxygen therapy technologies.

Pneumonia: Pneumonia represents nearly 10% of the Oxygen Therapy Market share due to the frequent requirement for oxygen support among patients experiencing severe respiratory infections. Hospitals commonly use oxygen therapy to stabilize patients with reduced oxygen saturation caused by lung inflammation.

The increasing incidence of respiratory infections and seasonal outbreaks continues driving demand for oxygen delivery systems. More than 2 million severe pneumonia cases annually require advanced respiratory assistance, supporting healthcare investments in oxygen therapy equipment.

Others: Other applications contribute approximately 5% of the Oxygen Therapy Market share and include additional respiratory conditions requiring oxygen supplementation. These applications cover various acute and chronic conditions where maintaining adequate oxygen levels is essential for patient recovery.

Increasing healthcare access and improving diagnosis capabilities are expanding the use of oxygen therapy across multiple medical scenarios. healthcare facilities are broadening respiratory care services to support diverse patient requirements.

Regional Outlook Of Oxygen Therapy Market

Global Oxygen Therapy Market Share, by Type 2035

Get Comprehensive Insights into the Market’s Size and Growth Trends

download Download FREE Sample

North America

North America is expected to maintain its leadership position in the Oxygen Therapy Market due to advanced healthcare infrastructure, high respiratory disease prevalence, and strong adoption of home-based oxygen therapy solutions. The region is estimated to account for approximately 38% of the global market share in 2026. Increasing demand for portable oxygen systems, advanced respiratory devices, and improved patient monitoring technologies is supporting regional growth.

The United States represents the largest contributor within North America due to significant healthcare spending and increasing cases of chronic respiratory disorders. More than 16 million adults in the country experience chronic respiratory conditions, creating sustained demand for oxygen source equipment and oxygen delivery devices. Growing adoption of home healthcare models and remote respiratory monitoring solutions is further strengthening market expansion.

Europe

Europe represents a major market for oxygen therapy solutions due to increasing elderly populations, rising respiratory disease cases, and strong healthcare system capabilities. The region is projected to account for approximately 28% of the global market share in 2026. Countries including Germany, the United Kingdom, France, and Italy are investing in advanced respiratory care infrastructure to improve patient treatment outcomes.

European healthcare providers are increasingly adopting portable oxygen delivery devices to support patients requiring long-term respiratory assistance.Healthcare organizations in major European economies are focusing on home-based care strategies to reduce hospital dependency and improve patient comfort.

Asia-Pacific

Asia-Pacific is projected to experience significant growth in the Oxygen Therapy Market due to expanding healthcare infrastructure, increasing respiratory disease burden, and rising awareness regarding advanced treatment options. The region is estimated to capture approximately 25% market share in 2026, supported by growing investments across China, India, Japan, and South Korea.

Rapid urbanization, increasing pollution levels, and improving healthcare accessibility are driving demand for oxygen therapy solutions across Asia-Pacific.Healthcare facilities in emerging economies are increasing investments in respiratory care equipment to address growing patient requirements.

Middle East and Africa

The Middle East and Africa region is witnessing gradual adoption of oxygen therapy technologies due to healthcare modernization programs, increasing hospital development, and rising demand for respiratory support systems. The region is expected to represent approximately 6% of the global market share in 2026.

Government investments in healthcare infrastructure and increasing availability of advanced medical equipment are supporting market development. Healthcare providers in developing markets are improving respiratory care capabilities through investments in oxygen generation and delivery technologies.

Rest of World

The Rest of World region, including Latin America and other emerging markets, is showing steady growth in oxygen therapy adoption due to improving healthcare access and increasing awareness of respiratory disease management. The region is estimated to account for approximately 3% of global market share in 2026.

Healthcare providers in these regions are increasingly adopting affordable oxygen therapy solutions to address respiratory care needs. Healthcare facilities in developing markets are focusing on expanding essential respiratory treatment services, supporting future demand for oxygen therapy equipment.

List of Top Oxygen Therapy Market Companies

  • Invacare Corporation
  • HERSILL
  • Koninklijke Philips N.V.
  • DeVilbiss Healthcare LLC
  • Teleflex Incorporated
  • Essex Industries, Inc.
  • Thermo Fisher Scientific Inc.
  • Smith Group plc.
  • Nidek Medical Products, Inc
  • General Electric
  • Tecno-Gaz S.p.A
  • Allied Healthcare Products, Inc.
  • OxyBand Technologies

Top 2 Companies By Highest Market Share

  • Koninklijke Philips N.V.: Koninklijke Philips N.V. maintains a strong position in the Oxygen Therapy Market through its advanced respiratory care portfolio, patient monitoring capabilities, and focus on home healthcare solutions. The company provides oxygen therapy technologies designed to support hospitals, clinics, and homecare environments. Philips benefits from increasing demand for connected respiratory devices, portable oxygen solutions, and digital healthcare management platforms. With more than 50% of respiratory care providers moving toward home-based treatment models, the company continues strengthening its presence through innovations focused on patient comfort, treatment efficiency, and remote monitoring capabilities.
  • Invacare Corporation: Invacare Corporation holds a significant position in the Oxygen Therapy Market through its focus on home respiratory care equipment and mobility-oriented oxygen solutions. The company develops oxygen source equipment and oxygen delivery devices designed for long-term respiratory support. Increasing demand for portable oxygen systems among elderly patients and individuals with chronic respiratory conditions supports the company’s market presence. More than 60% of home oxygen therapy users prefer lightweight and convenient devices, encouraging manufacturers such as Invacare to expand their product offerings with improved portability, reliability, and patient-focused designs.

Oxygen Therapy Market Investment Analysis And Opportunities

Investment activity in the Oxygen Therapy Market is increasing as healthcare providers prioritize respiratory care infrastructure, home healthcare expansion, and advanced oxygen delivery technologies. Companies are allocating resources toward developing compact oxygen systems, digital monitoring solutions, and energy-efficient equipment. More than 50% of healthcare organizations are increasing investments in respiratory support technologies to address growing demand from chronic respiratory disease patients.

Investments are also expanding in emerging markets where healthcare infrastructure development is improving access to oxygen therapy solutions. Manufacturers are focusing on affordable oxygen source equipment and scalable healthcare technologies to support broader adoption. Approximately 40% of medical device investments are being directed toward improving respiratory care accessibility, device efficiency, and patient management capabilities.

New Product Development

Oxygen therapy manufacturers are increasingly developing innovative products focused on portability, connectivity, and improved patient experience. New oxygen delivery devices are being designed with lightweight structures, longer battery performance, and enhanced monitoring capabilities. Nearly 60% of recent respiratory device innovations emphasize improving mobility and supporting home-based treatment approaches.

Companies are also investing in smart oxygen therapy solutions that integrate digital monitoring and healthcare management systems. These developments help healthcare providers track patient oxygen usage and improve treatment decisions. Around 45% of newly introduced respiratory care products are incorporating connected features to support personalized oxygen therapy management.

Five Recent Developments

  • January 2026 – Portable Oxygen Device Innovations Manufacturers introduced improved portable oxygen therapy devices featuring enhanced battery efficiency and lightweight designs to support increasing demand for home-based respiratory care.
  • April 2026 – Digital Respiratory Monitoring Expansion Healthcare technology companies expanded connected oxygen therapy solutions with remote monitoring capabilities to improve patient tracking and treatment management.
  • July 2026 – Advanced Oxygen Concentrator Launches Leading medical device providers introduced next-generation oxygen concentrators designed to improve oxygen delivery efficiency and reduce operational complexity.
  • October 2026 – Homecare Respiratory Solution Growth Companies increased focus on homecare respiratory products as healthcare systems expanded remote treatment models for chronic respiratory conditions.
  • January 2027 – Smart Oxygen Therapy Platforms Development Market participants accelerated development of intelligent oxygen management platforms integrating monitoring technologies to enhance patient care outcomes.

Report Coverage Of Oxygen Therapy Market

The Oxygen Therapy Market report provides comprehensive analysis of industry trends, market dynamics, segmentation, regional performance, competitive landscape, and technology advancements. The study evaluates Oxygen Source Equipment and Oxygen Delivery Devices while examining applications including Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Cystic Fibrosis, Pneumonia, and Others.

The report also covers strategic developments, investment patterns, product innovations, and emerging opportunities influencing market growth. Regional assessment includes North America, Europe, Asia-Pacific, Middle East and Africa, and Rest of World, highlighting factors shaping oxygen therapy adoption across healthcare systems.

Oxygen Therapy Market Report Coverage

REPORT COVERAGE DETAILS

Market Size Value In

USD 18104.97 Million in 2026

Market Size Value By

USD 45197.48 Million by 2035

Growth Rate

CAGR of 10.7% from 2026-2035

Forecast Period

2026 - 2035

Base Year

2025

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type :

  • Oxygen Source Equipment
  • Oxygen Delivery Devices

By Application :

  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Obstructive Sleep Apnea
  • Respiratory Distress Syndrome
  • Cystic Fibrosis
  • Pneumonia
  • Others

To Understand the Detailed Market Report Scope & Segmentation

download Download FREE Sample

Frequently Asked Questions

The global Oxygen Therapy Market is expected to reach USD 45197.48 Million by 2035.

The Oxygen Therapy Market is expected to exhibit a CAGR of 10.7% by 2035.

Invacare Corporation,HERSILL,Koninklijke Philips N.V.,DeVilbiss Healthcare LLC,Teleflex Incorporated,Essex Industries, Inc.,Thermo Fisher Scientific Inc.,Smith Group plc.,Nidek Medical Products, Inc,General Electric,Tecno-Gaz S.p.A,Allied Healthcare Products, Inc.,OxyBand Technologies.

In 2025, the Oxygen Therapy Market value stood at USD 16354.98 Million.

faq right

Our Clients

Captcha refresh

Trusted & Certified